Description
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Cas No. | 2446480-97-1 |
|---|---|
| Purity | ≥98% |
| Formula | C27H25F3N8O |
| Formula Wt. | 534.55 |
| IUPAC Name | 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine |
| Synonym | USP1-IN-1; KSQ4279 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cadzow L, Brenneman J, Sullivan P, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020 Oct 1;138(Supplement 2,S52).
Cadzow L, Tobin E, Sullivan P, et al. Abstract ND01: KSQ-4279: A first-in-class USP1 inhibitor for the treatment of cancers with homologous recombination deficiencies. Cancer Res. 2022;82(12_Supplement):ND01.
Neutrophil elastase inhibitor.
FAAH inhibitor.
Fermentation impurity
M3 mAChR antagonist.
α1-Adrenergic antagonist.
Monoterpene coumarin ether found in Citrus; PPA...
LBQ657 prodrug; neprilysin inhibitor.
Aminoglycoside; protein translation inhibitor.<...
Selective cannabinoid receptor 2 (CB2) inverse ...
Targets nuclear factor kappa B activation.
Endogenous neuropeptide, involved in energy hom...
2-methyl-1,4-naphthoquinone derivative
Synthetic vasopressin derivative; V2R agonist.<...
Read-through agent and nonsense mutation target...
Amino sugar, sorbitol derivative, used as a bul...
Aureothricin is a member of the dithiolopyrrolo...
Endogenous component of sphingolipids; PKC inhi...
Xanthine oxidase inhibitor.
Roscovitine analog; CDK inhibitor.